BOWDOIN, ME – FHC, Inc., a global manufacturer of products for the neuroscience industry, has announced the internal promotion of two employees.
Andy Haer has been named Director of Customer Collaboration. With 15 years of product development and promotion experience, he will oversee the Marketing & Communications, Business Development, and Sales/Tech Support departments to ensure complete customer satisfaction. His responsibilities will include managing the evolution of existing products and the development of new products, as well as the sales and marketing of all FHC technology. Mr. Haer joined FHC in 2014 as the Director of Business Development. He studied computer science at Northeastern University and has over 25 years of experience as a Windows application and driver software developer.
David Solt has been named the Director of Operations. In this role, Mr. Solt will provide the leadership and vision necessary to ensure that the company has the proper process controls, reporting procedures, and personnel to achieve operating efficiency in accordance with FHC’s yearly business plan. Mr. Solt earned a MS in Engineering from Penn State University, as well as a BS in Electrical Engineering and a MBA from Syracuse University. Prior to joining FHC in October of 2017, Mr. Solt served as the VP of R&D and Regulatory Affairs for InfraScan, Inc. in Philadelphia, PA and has over thirty years of experience in medical devices.
FHC, Inc. has served the neuroscience community for 48 years in its mission to advance cranial microTargeting worldwide. With a guiding principle of innovation through collaboration, FHC designs, manufactures, and internationally markets products that provide pioneering solutions for neuroscientists, neurologists, and neurosurgeons. FHC is headquartered in Bowdoin, Maine and operates globally with locations in Pennsylvania, South America and Europe.